MRI-guided focused ultrasound (MRgFUS) system for thermal ablation of prostate cancer: pre-clinical evaluation in canines

A transrectal MRgFUS system was tested in a canine prostate model. Focal volumes in each half of the prostate were targeted, with high energy in one half of the gland for ablation and in the other with lower-energy sonications to test our ability to localize the focal spot before causing thermal tissue damage. All sonications (n=155) were readily observed with proton resonance frequency (PRF) MR temperature imaging, contrast enhanced MRI and histology. The prostate gland moved during the experiments, demonstrating the need for motion tracking. The resultant focal temperature changes during the experiments were 24.2 ± 8.2°C.

[1]  C. Lawton.  Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer , 2009 .

[2]  Mark Emberton,et al.  Photodynamic therapy for prostate cancer—a review of current status and future promise , 2009, Nature Clinical Practice Urology.

[3]  Bernhard Walter,et al.  First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. , 2008, European urology.

[4]  Toyoaki Uchida,et al.  Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer , 2006, International journal of urology : official journal of the Japanese Urological Association.

[5]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[6]  K. Hynynen,et al.  The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array. , 2000, Physics in medicine and biology.

[7]  J. Chapelon,et al.  Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[8]  K Hynynen,et al.  Intracavitary ultrasound phased arrays for prostate thermal therapies: MRI compatibility and in vivo testing. , 1998, Medical physics.

[9]  K. Kuroda,et al.  A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.

[10]  J P Donohue,et al.  High-intensity focused ultrasound in the treatment of prostatic tissue. , 1994, Urology.

[11]  K. Hynynen,et al.  The role of nonlinear ultrasound propagation during hyperthermia treatments. , 1991, Medical physics.

[12]  W. Dewey,et al.  Thermal dose determination in cancer therapy. , 1984, International journal of radiation oncology, biology, physics.

[13]  S D Prionas,et al.  The effects of hyperthermia on normal mesenchymal tissues. Application of a histologic grading system. , 1983, Archives of pathology & laboratory medicine.